Catalyst Pharmaceuticals, Inc. (CPRX)

USD 21.35

(-3.26%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 471.9 Million 375.63 Million 237.78 Million 192.35 Million 112.37 Million 60.44 Million
Total Current Assets 219.32 Million 320.79 Million 210.1 Million 159.24 Million 111.36 Million 55.18 Million
Cash And Short Term Investments 137.63 Million 298.39 Million 191.26 Million 140.27 Million 94.51 Million 53.48 Million
Cash and Cash Equivalents 137.63 Million 298.39 Million 171.44 Million 130.23 Million 89.51 Million 16.55 Million
Short Term Investments - - 19.82 Million 10.04 Million 5 Million 36.92 Million
Net Receivables 53.51 Million 10.43 Million 6.61 Million 5.98 Million 10.53 Million -
Inventory 15.64 Million 6.8 Million 7.87 Million 4.65 Million 1.95 Million 56.01 Thousand
Other Current Assets 12.53 Million 5.15 Million 4.35 Million 8.32 Million 4.35 Million 1.64 Million
Total Non-Current Assets 252.57 Million 54.83 Million 27.68 Million 33.1 Million 1.01 Million 5.26 Million
Net PPE 3.7 Million 3.61 Million 3.97 Million 129.8 Thousand 1 Million 245.42 Thousand
Good Will And Intangible Assets 194.04 Million 32.47 Million - - - -
Good Will - - - - - -
Intangible Assets 194.04 Million 32.47 Million - - - -
Long-Term Investments 16.48 Million - - - - 5 Million
Tax Assets 38.33 Million 18.73 Million 23.69 Million 32.97 Million - -
Other Non Current Assets -1.00 9000.00 9000.00 8888.00 8888.00 8888.00
Other Assets 1.00 - - - - -
Total Liabilities 84.02 Million 75.2 Million 30.95 Million 22.75 Million 24.74 Million 9.66 Million
Total Current Liabilities 76.06 Million 57.58 Million 27.06 Million 22.75 Million 24.09 Million 9.51 Million
Account Payables 14.79 Million 3.97 Million 2.76 Million 4.25 Million 4.11 Million 2.33 Million
Tax Payables 729 Thousand 8.7 Million 79 Thousand - 1.53 Million -
Short Term Debt 369 Thousand 337 Thousand 308 Thousand 28.77 Thousand 300.51 Thousand -33.4 Thousand
Deferred Revenue 729 Thousand - 23.74 Million 18.36 Million 19.5 Million 33.4 Thousand
Other Current Liabilities 60.17 Million 53.27 Million 243 Thousand 107.03 Thousand 172.33 Thousand 7.17 Million
Total Non Current Liabilities 7.96 Million 17.62 Million 3.89 Million - 647.53 Thousand 154.79 Thousand
Long-Term Debt 3.18 Million 3.55 Million 3.89 Million - 647.53 Thousand -
Deferred Revenue Non Current -1.00 -1.34 Million - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.98 Million 14.06 Million - - - 154.79 Thousand
Other Liabilities 1.00 - - - - -
Total Equity 387.88 Million 300.42 Million 206.83 Million 169.59 Million 87.62 Million 50.78 Million
Stock Holders Equity 387.88 Million 300.42 Million 206.83 Million 169.59 Million 87.62 Million 50.78 Million
Common Stock 107 Thousand 105 Thousand 103 Thousand 103.78 Thousand 103.39 Thousand 102.73 Thousand
Retained Earnings 121.27 Million 49.86 Million -26.31 Million -53.7 Million -128.68 Million -160.56 Million
Accumulated other comprehensive income 14 Thousand 24 Thousand -148 Thousand 31.33 Thousand 9505.00 -20.24 Thousand
Common Stock Equity 387.88 Million 300.42 Million 206.83 Million 169.59 Million 87.62 Million 50.78 Million
Capital Lease Obligation 3.18 Million 3.55 Million 3.89 Million 29 Thousand 647.53 Thousand -
Total Investments 16.48 Million - 19.82 Million 10.04 Million 5 Million 41.93 Million
Total Debt 3.55 Million 3.89 Million 3.89 Million 28.77 Thousand 647.53 Thousand -
Net Debt -134.07 Million -294.5 Million -167.55 Million -130.2 Million -88.86 Million -16.55 Million

Balance Sheet Charts